Stifel bumps Nvidia stock target, sees attractive valuation
Investing.com - Aptevo Therapeutics reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Aptevo Therapeutics announced earnings per share of $-1.50 on revenue of $0.00. Analysts polled by Investing.com EPS of $-1.35 on revenue of $1.85M.
Aptevo Therapeutics 's are up 25.4% and is trading at $2.89 , still down 87.14% from its 52 week high of $22.08 set on Tuesday, November 23, 2021.
Aptevo Therapeutics follows other major Healthcare sector earnings this month
Aptevo Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar